Finoso Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 16-07-2024
- Paid Up Capital ₹ 3.02 Cr
as on 16-07-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 Cr
as on 16-07-2024
- Satisfied Charges ₹ 2.45 Cr
as on 16-07-2024
- Revenue -7.48%
(FY 2023)
- Profit -207.58%
(FY 2023)
- Ebitda -83.43%
(FY 2023)
- Net Worth -13.71%
(FY 2023)
- Total Assets 17.03%
(FY 2023)
About Finoso Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.02 Cr.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹2.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Finoso Pharma Private Limited India is Ramakanta Tripathy as CFO. Kunapareddy Prasad and Dillip Jena serve as directors at the Company.
- CIN/LLPIN
U24231TG2009PTC064774
- Company No.
064774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Finoso Pharma Private Limited offer?
Finoso Pharma Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Product Development Research, Analytical Method Development Services, Formulation Development Service, Analytical Development Services, Direct Tax Service, Income Tax Filing.
Who are the key members and board of directors at Finoso Pharma?
Executive Team (1)
RT
Ramakanta Tripathy
CFOAppointment Date: 22-Feb-2022
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Finoso Pharma.
Finoso Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.48% decrease. The company also saw a substantial fall in profitability, with a 207.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Finoso Pharma?
In 2023, Finoso Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
41 years 4 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 31 Dec 2014 | ₹4.50 Cr | Open |
State Bank Of India Creation Date: 28 Oct 2009 | ₹2.45 Cr | Satisfied |
How Many Employees Work at Finoso Pharma?
Finoso Pharma has a workforce of 12 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 26, 2014, Finoso Pharma has raised a total of ₹ 6.92 Cr, with the most recent deal valued at ₹ 2 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
